Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2026-03-18

Clinical Trial Update: Study of the Interest of Pursuing or Not the Chemotherapy for Patients With Metastatic Esophageal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating whether to pursue chemotherapy for metastatic esophageal squamous cell carcinoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Centre Oscar Lambret | Conditions: Esophageal Cancer, Squamous Cell | Phase 2 | Status: TERMINATED